Carl Anderson
Advertisement
Articles by Carl Anderson
Shedding light on common EMR concerns about privacy, government regulations, and data integrity.
Carl Anderson, senior consultant for Biologics Consulting Group, addresses the frequent overuse of Notes to File and concludes that documenting a mistake means absolutely nothing during an FDA inspection.
Advertisement
Latest Updated Articles
Key Updates to the 1572Published: May 23rd 2012 | Updated:
Note to File (NTF) is Not an FDA PanaceaPublished: March 1st 2008 | Updated:
The Ins and Outs of Electronic Medical RecordsPublished: September 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Evolution of Global Trial Strategies in Today's Complex Healthcare Landscape
2
ACT Brief: Global Trials Scale Up, Site-Centric Startup Gains Focus, and Pfizer Expands Vaccine Partnerships
3
FDA RWE Guidance Redefines Data Use in Clinical Operations
4
ACT Brief: Life Sciences Hold the Line on DEI, Startup Timelines Stretch Further, and Regulators Align on AI Governance
5